Cargando…
Emerging links between m(6)A and misregulated mRNA methylation in cancer
N (6)-methyladenosine (m(6)A) in mRNA has emerged as a crucial epitranscriptomic modification that controls cellular differentiation and pluripotency. Recent studies are pointing to a role for the RNA methylation program in cancer self-renewal and cell fate, making this a new and promising therapeut...
Autores principales: | Jaffrey, Samie R., Kharas, Michael G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228104/ https://www.ncbi.nlm.nih.gov/pubmed/28081722 http://dx.doi.org/10.1186/s13073-016-0395-8 |
Ejemplares similares
-
mRNA ageing shapes the Cap2 methylome in mammalian mRNA
por: Despic, Vladimir, et al.
Publicado: (2023) -
Expanding the epitranscriptome: Dihydrouridine in mRNA
por: Dixit, Sameer, et al.
Publicado: (2022) -
Alternative splicing of METTL3 explains apparently METTL3-independent m(6)A modifications in mRNA
por: Poh, Hui Xian, et al.
Publicado: (2022) -
m(6)A enhances the phase separation potential of mRNA
por: Ries, Ryan J., et al.
Publicado: (2019) -
m(6)A RNA Methylation Maintains Hematopoietic Stem Cell Identity and Symmetric Commitment
por: Cheng, Yuanming, et al.
Publicado: (2019)